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outcome measures.  Results: Participation in FR, GI and FR/GI 
led to increases in FEV 1 (% predicted) of 7.6  8 13.2, 3.3  8 9.8, 
and 8.3  8 21.0, respectively, as compared to –1.8  8 11.1 in 
the CI group at the end of the therapy. After follow-up, the 
increases in FEV 1 were 6.9  8 10.3 in the FR group, 4.4  8 7.3 
in the GI and 4.5  8 8.1 in the FR/GI, compared to –2.8  8 9.2 
in the CI. Improvements in sR aw (% predicted) were in keep-
ing with the changes in FEV 1 in all groups.  Conclusions: Our 
study confirms a positive effect of FR on respiratory param-
eters and suggests a clinically relevant long-term benefit 
from FR as a nonpharmacological and complementary ther-
apy treatment option. 
 
Copyright © 2009 S. Karger AG, Basel 
 Introduction 
 Asthma is a frequently disabling and almost invari-
ably distressing disease that has a prevalence of between 
2 and 8% in adults  [1] and up to 21% in children  [2] . Ac-
cording to Eder et al.  [3] , there is evidence that, in some 
areas of the Western world, the prevalence of asthma may 
have plateaued at this very high level.
 Key Words 
 Asthma   Functional relaxation   Guided imagery   Body 
psychotherapy   Randomized controlled trial 
 Abstract 
 Background: Asthma is a frequently disabling and almost 
invariably distressing disease that has a high overall preva-
lence. Although relaxation techniques and hypnotherapeu-
tic interventions have proven their effectiveness in numer-
ous trials, relaxation therapies are still not recommended in 
treatment guidelines due to a lack of methodological qual-
ity in many of the trials. Therefore, this study aims to investi-
gate the efficacy of the brief relaxation technique of func-
tional relaxation (FR) and guided imagery (GI) in adult 
asthmatics in a randomized controlled trial.  Methods: 64 pa-
tients with extrinsic bronchial asthma were treated over a 
4-week period and assessed at baseline, after treatment and 
after 4 months, for follow-up. 16 patients completed FR, 14 
GI, 15 both FR and GI (FR/GI) and 13 received a placebo relax-
ation technique as the control intervention (CI). The forced 
expiratory volume in the first second (FEV 1 ) as well as the 
specific airway resistance (sR aw ) were employed as primary 
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 Asthma is a disease of multifactorial etiology  [4, 5] . 
Regarding the modulation of the course of disease, Mathé 
and Knappe  [6] have already found that psychological 
stress is associated with a decrease in airway resistance in 
healthy individuals but with an increase in those with 
asthma. On the one hand this presents a fundamental 
paradox, in as much as several components of the gener-
ic stress response (i.e. glucocorticoid release from the ad-
renal cortex or increased activity in the sympathetic ner-
vous system) should in principle lead to bronchodilata-
tion rather than bronchoconstriction. On the other hand, 
it shows that the idea of a generic stress response is an 
oversimplification and the precise psychophysiological 
regulation of respiratory airflow remains unclear  [7] .
 However, since the importance of emotional factors in 
triggering asthma attacks has been recognized  [8, 9] , it 
has been suggested that psychological treatment methods 
may influence airway caliber by balancing the activity of 
the autonomous nervous system. Several psychological 
interventions may be employed to ameliorate health 
problems associated with asthma, as summarized by 
Yorke et al.  [10] . There seem to be differential effects, with 
some evidence for a reduction in relief medications after 
relaxation therapy, improvement of asthma-related qual-
ity of life following cognitive behavioral therapy and peak 
expiratory flow outcome being positively influenced in 
biofeedback therapy  [10] .
 The adequate management of asthmatic complaints 
relies heavily on the patient’s ability to detect changes in 
breathing, to assess these changes accurately and to re-
spond to them appropriately  [11] . These considerations 
have led to the use of complementary relaxation tech-
niques and body-psychotherapeutic methods for improv-
ing body awareness and better regulation of the auto-
nomic nervous system.
 A large body of literature  [12] exists regarding the use 
of relaxation techniques in the treatment of the symp-
toms of asthma. These techniques include jacobsonian 
progressive relaxation  [13] , hypnotherapy  [14] , autogenic 
training  [15] , biofeedback training  [16] and approaches 
based on mindfulness, such as yoga  [17] . As shown in a 
critical review by Brown  [18] , hypnosis is efficacious in 
managing emotional states that exacerbate airway ob-
struction and may possibly stabilize airway hyperrespon-
siveness in some individuals. Freeman and Welton  [19] 
reported that imagery interventions led to significant 
symptomatic improvements in adult asthmatics. Promis-
ing results have also been shown in several studies using 
the technique of functional relaxation (FR), a brief relax-
ation technique based on the principles of psychodynam-
ic body psychotherapy. In two trials  [20, 21] FR led to 
significant improvements in pulmonary function in 
asthma patients, with effect sizes comparable to those in-
duced by inhaled   2 -sympathomimetics.
 Despite these findings, there is still a lack of evidence 
regarding the efficacy of relaxation therapies in the man-
agement of asthma, which is largely due to some method-
ological limitations in previous studies  [12] . Many of the 
previous trials do not fulfill the criteria of randomized 
controlled trials as defined by the Consort Statement  [22] . 
Information regarding dropouts is often missing and the 
studies do not include a follow-up period for detecting 
the long-term stability of achieved short-term effects. Be-
cause of the above, relaxation and other complementary 
techniques are still not recommended in current asthma 
treatment guidelines  [23] .
 We therefore carried out a randomized controlled tri-
al that aimed to compare the brief relaxation technique 
of FR with guided imagery (GI) in adult asthmatics. In 
addition to the methods applied in previous studies that 
addressed the efficacy of FR  [20, 21] , the present trial fo-
cused on the long-term effects of FR by including a 4-
month follow-up assessment.
 Methods 
 Participants 
 Patients suffering from allergic bronchial asthma due to dust 
mite allergy were recruited using a local newspaper advertise-
ment, which was answered by 291 patients. The inclusion crite-
rion was a diagnosis of controlled allergic asthma already estab-
lished by a pulmonologist/allergologist at a university hospital 
outpatient clinic for respiratory diseases. Diagnostics included a 
positive history of dyspnea upon exposure to house dust, physical 
examination, lung function tests and a positive prick test to a 
standardized dust mite extract  (Dermatophagoides pteronyssinus 
and/or  Dermatophagoides farinae) with a wheal diameter at least 
3 mm greater than the negative control. According to this crite-
rion, 75 suitable patients were identified. Exclusion criteria were 
defined as follows: age under 18 years, severe psychiatric or so-
matic disease other than allergic asthma, current use of any psy-
choactive medication or psychotherapy (including regular relax-
ation training), use of medication (anything other than the usual 
types of asthma medication prescribed by a chest physician) or 
modification of asthma medication during the previous 4 weeks 
or within the course of the trial. Furthermore, basic asthma med-
ication was kept stable throughout the trial.
 Current mental illness was excluded using a clinical face-to-
face interview. Potential participants received a comprehensive 
description of the study specifics, and 64 patients gave their 
written informed consent to participate. Those included were 
randomized to FR, GI, FR and GI (FR/GI) or a placebo relax-
ation technique as the control intervention (CI) using random-
ized numbers generated by an Excel table ( fig. 1 ). Randomiza-
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tion was carried out in confidence by a study nurse, with alloca-
tion concealment using a randomization list created before the 
study.
 With a sample size of 14 patients per group, the study was de-
signed to detect differences in specific airway resistance (sR aw ) 
change between the control and intervention groups of 130 kPa/s 
with 80% power, assuming a common standard deviation of 100 
kPa/s and considering an overall type I error level of 0.05. These 
assumptions correspond to the results of a small pilot study. 64 
patients were randomized, with a loss to follow-up of 5 patients 
due to incomplete or missing data.
 Assessment 
 The standard pulmonary function indicators were measured 
using a spirometer and a body plethysmograph (Jaeger  ), always 
at the same time of the day. These included standard assessments 
of forced expiratory volume per second (FEV 1 ) as a percentage of 
the predicted value and the sR aw , also reported as a percentage of 
the predicted value. The best of 3 satisfactory FEV 1 and sR aw tests 
was recorded. Normal values were calculated from the sex, height 
and age of each patient, in order to compare the measured values 
with the normal values  [24] . The actual value of the lung function 
test is calculated as a percentage of the nominal value. The evalu-
ation considers the FEV 1 and the sR aw as products of the respira-
tory resistance and the intrathoracic gas volume. As it is indepen-
dent from patient cooperation, the sR aw is considered to be a sen-
sitive and reliable measure of resistance  [24] . An increase in the 
FEV 1 associated with a decrease in the sR aw  indicates a broncho-
dilatation. The average duration for a complete pulmonary func-
tion test was approximately 7 min. The data were analyzed by an 
online digital computer.
 Design 
 The time structure of the trial was identical for all conditions. 
After giving informed consent, the patients were randomized to 
FR, GI, FR/GI or the CI. The interventions were carried out over 
a period of 4 weeks in small groups of 3–5 persons, with 1 group 
session per week. The participants underwent lung function tests 
directly before (t0) and after finishing the therapies (t1) and again 
4 months later (t2). The test was always taken at the same time of 
the day using a standardized diagnostic procedure, as recom-
mended by the European Respiratory Society  [24] . On assessment 
days, the patients were not allowed to take any short-acting med-
ication before the examination, which prevented false results 
caused by potential contamination of effects. The study was com-
pleted according to the plan.
 Interventions 
 All interventions were carried out by a physician specialized 
in psychosomatic medicine and certified in functional relaxation 
and hypnotherapy, who was assisted by a PhD student.
 FR is a somatopsychotherapeutic intervention technique com-
monly used in Germany, Austria and Switzerland for the treat-
ment of psychosomatic disorders  [25, 26] . The therapeutic effects 
are assumed to be delivered by positive stimulation of the auto-
nomic nervous system as well as by facilitation of propriorecep-
tive awareness  [27] . Minute movements of small joints, hardly no-
ticeable to observers, are performed during relaxed expiration, 
Assessed for
eligibility
(n = 291)
Randomized
(n = 64)
Functional relaxation
(n = 16)
Guided imagery
(n = 16)
Control intervention
(n = 16)
Functional relaxation
and guided imagery
(n = 16)
Follow-up t1
(n = 16)
Follow-up t1
(n = 16)
Follow-up t1
(n = 16)
Follow-up t1
(n = 15)
Follow-up t2
(n = 16)
Follow-up t2
(n = 15)
Follow-up t2
(n = 15)
Follow-up t2
(n = 14)
Excluded (n = 227; 
not meeting the inclusion
criteria n = 216; refused
to participate n = 11)
 Fig. 1. Flow diagram of the trial progress. 
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accompanied by a focus on and exploration of the perceived dif-
ferences of body feelings triggered by these movements. The focus 
of attention is thereby directed towards the way the person relates 
to the environment, particularly the floor as the foundation and 
as the ‘outer support’ to the bony skeleton (referred to in FR as ‘the 
frame’ or the ‘inner support’), to the interior regions of the body 
and to the skin as an ‘outer border’. Unlike exercise-based meth-
ods, such as progressive muscle relaxation, the bodily perceptions 
are explicitly verbalized and processed in the therapeutic rela-
tionship.
 In the FR treatment, the group therapy was guided by a man-
ual which was generated during previous investigations  [25, 28] . 
This concept has been adapted to the special features of asthmat-
ic patients.
 The GI intervention consisted of visualizing a set of standard-
ized guided imageries targeting the airways  [29] . In the first ses-
sion, participants were instructed in positive visualization of a 
situation with deep ‘free’ breathing. Additionally, the patients 
were encouraged to integrate this positive imagination into their 
daydreams. The second session started with a short educational 
section about allergy and the relevance of mast cells, followed by 
an exercise to imagine the mast cells acting to alleviate the hyper-
sensitive bronchial system. The third session focused on a healthy 
self-perception, including imagining a better physical condition 
in the future. The last session provided time for repetition of the 
aforementioned topics.
 In the FR/GI group, the FR units were augmented by elements 
of imagery in each session.  In contrast, the CI consisted of iso-
tonic exercises, which required – in comparison to FR – an equiv-
alent amount of movement, but which did not involve the chest, 
shoulders, neck or head. This intervention did not focus on en-
hancing bodily selfawareness, as in FR, neither did it include 
imaginative elements, as in GI. During the isotonic exercises the 
patients were instructed to hold specific postures for several min-
utes in a relaxed manner. To enhance its credibility, the patients 
were told that this new technique was called focused body aware-
ness training.
 In the interest of minimizing potential therapist bias, all 3 
forms of intervention were conducted by the same therapeutic 
team. The time structure was the same in every group with one 
60-min session weekly and a total of 4 sessions over a 4-week-pe-
riod. The therapy sessions were videotaped and supervised by an 
independent, certified body psychotherapist, ensuring that the 
therapists adhered to the manual.
 Statistical Analysis 
 Statistical analyses were performed using SPSS software v.15.0 
(SPSS Inc., Chicago, Ill., USA). The patients’ basic data were char-
acterized by descriptive statistics. The   2 test and analysis of vari-
ance (ANOVA) were used for exploratory comparisons of social 
demographic data and baseline values between intervention 
groups. Analysis of covariance (ANCOVA) was employed for an-
alyzing differences in long-term change of the primary outcome 
parameters FEV 1 and sR aw between the control and intervention 
groups. Baseline FEV 1 and sR aw  were included as adjustment co-
variates in order to control for the impact of initial value levels 
and different distributions in treatment groups. All statistical 
analyses were performed two-sided at a 0.05 level of significance. 
To adjust for multiple group comparisons, Bonferroni correction 
of p values was conducted. To minimize the required correction 
level in multiple test procedures, statistical comparisons of inter-
vention groups were solely conducted for the clinically relevant 
changes of FEV 1 and sR aw between measurement 2 and baseline. 
Statistical evaluation was carried out according to the intention-
to-treat principle.
 Source of Funding and Ethical Considerations 
 The study was planned and conducted in accordance with the 
Declaration of Helsinki and ethical laws pertaining to the medical 
professions. The design was approved by the ethics committee of 
the Statutory Physician Board. This study was conducted without 
any institutional influence and was not funded externally.
 Results 
 The study sample consisted of 64 patients. The aver-
age age of all participants was 42.9  8 12.2 years, 64% 
were female. No statistically significant group differ-
ences were found between the 3 treatment groups re-
garding sociodemographics (age, sex, partnership and 
professional status) and baseline measurements at t0. 
 Tables 1 and  2 show the explorative analysis of the out-
come parameters FEV 1 and sR aw over the course of the 
trial. No statistically significant differences were found 
in mean baseline values. Controller or reliever medica-
tion was kept stable in all patients throughout the study. 
All p values reported here resulted from group compar-
isons of changes in FEV 1 and/or sR aw  (from baseline to 
t2) with CI as a comparison group, and they are adjust-
ed for baseline FEV 1 and sR aw ,   respectively. Bonferroni 
correction of p values was used in order to apply an 
overall level of significance of 5% in the face of multiple 
testing.
 Participation in the FR, GI, FR/GI and CI groups led 
to increases in FEV 1 (% predicted) of 7.6  8 13.2, 3.3  8 
9.8 and 8.3  8 21.0, respectively, as compared to –1.8  8 
11.1 in the CI group at the end of the therapy phase. At t2, 
the increases in FEV 1 were 6.9  8 10.3 (p = 0.009) in the 
FR group, 4.4  8 7.3 (p = 0.072) in the GI, 4.5  8 8.1 (p = 
0.066) in the FR/GI and –2.8  8 9.2 in the CI. While the 
most beneficial effect regarding FEV 1 at t1 could be seen 
in patients who participated in FR/GI (followed by FR 
and GI alone, with a slight decrease in the CI group), a 
long-lasting effect at t2 could only be observed in the FR 
group, with a noticeable decrease in the benefit among 
FR/GI and GI patients and a further decline in the CI 
group. The analyses relating to changes in FEV 1 revealed 
that only the FR group reached a level of statistical sig-
nificance when compared to the CI.
 Regarding changes in sR aw (% predicted), at the end of 
the therapy phase (t1) the decreases in sR aw were –162.2 
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 8 56.6 in the FR group, –207.4  8 87.9 in the GI, –158.8 
 8 93.3 in the FR/GI and –265.3  8 111.5 in the CI. After 
the 4-month follow-up (t2), the decreases in sR aw were
–100.9  8 100.5 (p = 0.018) in the FR group, –51.7  8 165.2 
(p = 0.228) in the GI, –72.4  8 56.5 (p = 0.024) in the FR/
GI and 54.9  8 86.2 in the CI. At t1 the clearest positive 
effect in sR aw could be seen with FR, followed by FR/GI 
and GI alone, whereas even a minor aggravation of air-
way resistance could be observed in the group receiving 
the CI. This pattern was equal at t2, with a marginal de-
crease over time in the FR, FR/GI and GI groups and a 
slightly exacerbated aggravation in patients receiving the 
CI. Group comparisons revealed that improvements in 
the FR and FR/GI groups, but not in the GI group, reached 
a 0.05 level of significance at t2.
 No side effects from the interventions were reported 
by any of the patients, nor did any patients report diffi-
culties with implementing the body-psychotherapeutic 
technique of FR.
 Discussion 
 This study confirms earlier findings showing a posi-
tive effect from FR on lung parameters in patients with 
bronchial asthma  [20, 21] .
 In the present study we could demonstrate for the first 
time that effects achieved through FR remain stable at a 
4-month follow-up. While improvements in the GI group 
initially seemed clinically relevant, they dissipated sig-
nificantly more rapidly during the follow-up observation 
period. The effects of the combined FR/GI intervention 
fell in between those achieved in the other treatment 
groups. One could speculate that this differential effect is 
due to the active and individual FR approach, which al-
lows the patient to further apply individually modified 
exercise elements to various everyday situations over the 
course of the therapy phase and catamnesis.
 Little can be said regarding the therapeutic mecha-
nisms involved as no relevant information is available yet 
regarding the psychophysiological effects of body-orient-
Table 1. Measurement of FEV1 (% predicted) over the course of the trial
FEV1 t0 t1 t2
FR GI FR/GI CI FR GI FR/GI CI FR GI FR/GI CI
Patients 16 16 16 16 16 16 16 15 16 15 15 13
Mean
Standard deviation
80.2
16.1
80.8
17.7
81.8
13.5
82.1
16.2
87.8
14.5
84.1
15.4
84.9
12.2
80.8
19.0
87.1
14.5
85.6
15.5
85.7
14.0
76.9
19.7
Minimum 54 40 54 51 45 47 59 40 64 55 60 35
Maximum 105 105 106 113 101 104 100 107 112 109 106 108
25th percentile 65.8 72.0 70.0 72.0 84.0 71.3 77.5 70.0 74.0 73.0 73.0 71.5
50th percentile 81.0 82.0 84.0 80.5 91.5 86.0 88.0 83.0 88.5 89.0 89.0 78.0
75th percentile 96.5 94.8 90.0 92.8 97.5 97.0 92.5 97.0 99.5 98.0 96.0 92.0
Table 2. Measurement of sRaw (% predicted) over the course of the trial
sRaw t0 t1 t2
FR GI FR/GI CI FR GI FR/GI CI FR GI FR/GI CI
Patients 16 16 16 16 16 16 16 15 16 15 15 13
Mean
Standard deviation
286.3
123.6
252.9
149.9
249.6
111.9
226.1
85.6
162.2
56.6
207.4
87.9
158.8
93.3
258.6
112.4
185.4
71.3
203.1
117.5
172.9
91.5
267.6
94.3
Minimum 104 100 93 89 70 110 62 119 101 85 57 127
Maximum 512 638 494 443 271 372 450 531 382 517 379 436
25th percentile 193.3 129.5 150.8 166.5 128.5 138.8 92.5 198.0 136.8 112.0 100.0 204.5
50th percentile 243.0 212.5 254.0 209.5 149.5 174.5 145.0 215.0 170.5 185.0 167.0 229.0
75th percentile 405.8 348.8 314.0 285.8 180.5 251.5 195.8 302.0 216.8 216.0 232.0 365.0
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ed therapy or imagery techniques in asthma. As all pa-
tients included in the present trial suffered from allergic, 
and therefore immunoglobulin-E (IgE)-mediated asth-
ma, the effects may be partially due to a modulation of 
allergic antibody responses. Castés et al.  [30] demonstrat-
ed that a 6-month psychosocial intervention program, 
including relaxation, GI and self-esteem training, led not 
only to a clinically significant improvement, but also to a 
significant reduction in the specific IgE responses against 
 Ascaris lumbricoides (the most important allergen in the 
children in that study). Beyond potential modulation of 
the IgE-mediated inflammatory response, the observed 
benefits could be partially due to direct bronchodilata-
tory effects caused by FR or GI. The underlying mecha-
nism might be a mitigation of vagal stimulation, as ‘rebal-
ancing’ of the autonomic nervous system is assumed to 
be a possible mode of action of FR. Furthermore, the co-
incident reduction of asthma-associated anxiety presum-
ably accounts for improvements of lung function, as 
shown by Lolak et al.  [31] .
 The deterioration of sR aw and FEV 1 over time in the CI 
group might be explained by a negative placebo expecta-
tion, a so-called nocebo effect. The nocebo hypothesis 
proposes that expectations of sickness and the affective 
states associated with such expectations can cause sick-
ness in the expectant patient  [32] . All participants were 
informed about the possibility of being randomized to 
any 1 of the 3 different treatment settings (FR, GI, FR/GI) 
or to the control group. As the CI consisted only of an 
instruction of specific bodily postures without any spe-
cific movements or pictures for imagination, this inter-
vention was potentially unmasked as a placebo interven-
tion by a considerable proportion of participants. This 
might have led to a more pessimistic attitude towards the 
effectiveness of the intervention, and pessimists are 
known to be more likely to display a negative placebo (no-
cebo) expectation  [33] .
 This study has several methodological limitations. 
First, the sample size was relatively small, consisting of 
only 16 patients in each treatment condition. Since the 
follow-up period of this trial was only 4 months, the 
dropout rate might have been lower than in trials with a 
longer follow-up period.
 Given that the body-oriented therapy sessions were 
carefully designed and matched for possible nonspecific 
effects (e.g. attention given by the trainer or learning ef-
fects), it is difficult to claim that the outcome variables 
were influenced by nonspecific components of the FR 
treatment. However, one possible influence may be that 
the study was not conducted in an entirely double-blind 
setting. However, creating completely double-blind con-
ditions would not have been feasible, since it is impossible 
to prevent an experienced therapist knowing the kind of 
technique she/he is applying. However, a potential bias 
could arise from not checking the blinding of the pa-
tients. Although patients were not informed of which in-
tervention they were allocated to, we did not ask the par-
ticipants which intervention they believed themselves to 
be receiving. We also did not measure the degree of sub-
jectively perceived relaxation in the FR group or the de-
gree of vividness in the GI group. Although adherence of 
therapists to the treatment manual was controlled by 
continuous supervision, the adherence of patients to the 
given instructions was not measured in the trial.
 The present trial focused on the influence of FR, GI 
and FR/GI on lung parameters in patients with allergic 
asthma and, therefore, no subjective outcome parameters 
were measured. It has to be considered that improved 
physiological outcomes are not necessarily reflected in an 
improved asthma-related quality of life  [34] .
 Even considering the above limitations, the results of 
our study are promising because they show that body-
oriented therapy, such as FR, can lead to a significant re-
duction in the objective parameters of pulmonary ob-
struction in asthma which, furthermore, was shown to be 
maintained over a period of 4 months. These treatment 
benefits are the result of only 4 sessions of complemen-
tary body-oriented therapy, which can, therefore, be re-
garded as a feasible intervention that is an efficient use of 
time. Nevertheless, future research should consider fur-
ther the feasibility of body-oriented therapy in daily prac-
tice. Additional research is needed to ascertain if these 
results can be replicated, for how long the benefits last 
beyond a 4-month follow-up and if the regular comple-
mentary use of FR leads to clinically relevant improve-
ments in the long-term course, including improvement in 
health-related quality of life.
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